Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Belli

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Leukemia & Lymphoma|January 28, 2012
Prognostic relevance of cytogenetic systems in myelodysplastic syndromesCarolina B Belli, Yesica Bestach, Walter A Correa, et al.
The Veterinary Record|March 17, 2021
Equine simplified acute physiology score: Personalised medicine for the equine emergency patientAline de Matos Curvelo de Barros, Ana Flávia Rocha Silva, Miriam Zibordi, et al.
Gene|December 13, 2021
Expression dynamics of the immune mediators ARG1, TBET, CIITA, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapyMaría Jazmín Toloza, Yesica Bestach, Marco Lincango-Yupanki, et al.
Annals of Hematology|November 6, 2024
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemiaMaría Jazmín Toloza, Marco Lincango, María Fernanda Camacho, et al.
American Journal of Hematology|September 1, 2020
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patientsCarolina Lazzarino, Jorge Arbelbide, Sergio Schuster, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 10, 2024
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American CentersLucas Castelo, Wellington Fernandes da Silva, Marco Lincango, et al.
Annals of Hematology|May 1, 2021
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patientsJacqueline S González, María Agustina Perusini, Ana L Basquiera, et al.
Annals of Laboratory Medicine|July 26, 2024
Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation SequencingMarco Lincango, Verónica Andreoli, Hernán García Rivello, et al.
Bone Marrow Transplantation|January 31, 2017
Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantationM Berro, M V Palau Nagore, M M Rivas, et al.
American Journal of Hematology|June 25, 2015
Myelodysplastic syndromes in South America: a multinational study of 1080 patientsCarolina B Belli, Ronald Feitosa Pinheiro, Yesica Bestach, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Leukemia & Lymphoma|January 28, 2012
Prognostic relevance of cytogenetic systems in myelodysplastic syndromesCarolina B Belli, Yesica Bestach, Walter A Correa, et al.
The Veterinary Record|March 17, 2021
Equine simplified acute physiology score: Personalised medicine for the equine emergency patientAline de Matos Curvelo de Barros, Ana Flávia Rocha Silva, Miriam Zibordi, et al.
Gene|December 13, 2021
Expression dynamics of the immune mediators ARG1, TBET, CIITA, IL10 and TGFB1 in chronic myeloid leukaemia patients during the first year of imatinib therapyMaría Jazmín Toloza, Yesica Bestach, Marco Lincango-Yupanki, et al.
Annals of Hematology|November 6, 2024
Immune checkpoints PD1/PDL1, TIM3/GAL9 and key immune mediators landscape reveal differential expression dynamics on imatinib response in chronic myeloid leukemiaMaría Jazmín Toloza, Marco Lincango, María Fernanda Camacho, et al.
American Journal of Hematology|September 1, 2020
Severe thrombocytopenia as a predictor of survival and response to hypomethylating agents in myelodysplastic syndromes: A Latin-American cohort of 212 patientsCarolina Lazzarino, Jorge Arbelbide, Sergio Schuster, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 10, 2024
Alternative Dosing Schedules of Azacitidine: A Real-World Study Across South American CentersLucas Castelo, Wellington Fernandes da Silva, Marco Lincango, et al.
Annals of Hematology|May 1, 2021
Prognostic assessment for chronic myelomonocytic leukemia in the context of the World Health Organization 2016 proposal: a multicenter study of 280 patientsJacqueline S González, María Agustina Perusini, Ana L Basquiera, et al.
Annals of Laboratory Medicine|July 26, 2024
Assessing the Relevance of Non-molecular Prognostic Systems for Myelodysplastic Syndrome in the Era of Next-Generation SequencingMarco Lincango, Verónica Andreoli, Hernán García Rivello, et al.
Bone Marrow Transplantation|January 31, 2017
Transforming growth factor-β1 functional polymorphisms in myeloablative sibling hematopoietic stem cell transplantationM Berro, M V Palau Nagore, M M Rivas, et al.
American Journal of Hematology|June 25, 2015
Myelodysplastic syndromes in South America: a multinational study of 1080 patientsCarolina B Belli, Ronald Feitosa Pinheiro, Yesica Bestach, et al.
Pageof 4